Biopharmaceuticals Market Research Reports & Industry Analysis
Biopharmaceuticals are a class of drugs produced using living organisms or their cellular components to treat various medical conditions. By providing highly targeted and sophisticated therapeutic options, biopharmaceuticals have revolutionized the field of medicine. If you are in search of comprehensive and objective data on this fast-growing market, you have come to the right place. MarketResearch.com offers hundreds of biopharmaceuticals industry reports published by leading research firms.
New Biopharmaceuticals Market Research
- Use our reports to explore diverse markets in the biopharmaceuticals industry, from biosimilars to enzymes to antibodies.
- Gain invaluable insights, including biopharmaceuticals market size, growth, and industry trends.
- Get up to speed on the latest technological breakthroughs, opportunities, and market-entry strategies.
Proven Expertise in the Field of Market Research
With a track record spanning more than two decades, MarketResearch.com is a trusted source for market research. We serve top-tier investment banks, management consulting firms, and Fortune 500 multinational corporations. Our dedicated research specialists are here to provide recommendations and guidance throughout your research process. Improve your knowledge and enhance your strategies with biopharmaceutical market research from MarketResearch.com today.
Biopharmaceuticals Industry Research & Market Reports
-
Vietnam Generic Drugs Market, By Type (Small Molecule Generics v/s Biosimilars), By Mode of Drug Delivery (Oral, Topical, Parenteral, Others), By Form (Tablet, Capsule, Injection, Others), By Source (In House v/s Contract Manufacturing Organizations), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies), By Application (Cardiovascular Diseases, Diabetes, Neurology, Oncology, Anti-Inflammatory Diseases, Others), By Region, Competition Forecast & Opportunities, 2027
... Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies), By Application (Cardiovascular Diseases, Diabetes, Neurology, Oncology, Anti-Inflammatory Diseases, Others), By Region, Competition Forecast & Opportunities, 2027 Vietnam generic drugs market is projected to witness growth at ... Read More
-
North America Biosimilars Market Size, Share & Industry Trends Analysis Report By Application (Oncology Diseases, Blood Disorders, Chronic & Autoimmune Diseases and Others), By Type, By Country and Growth Forecast, 2022 - 2028
... America Biosimilars Market would witness market growth of 23.6% CAGR during the forecast period (2022-2028). Biosimilars are rigorously and thoroughly examined by the FDA before approval, and they are just as secure and efficient as ... Read More
-
Europe Biosimilars Market Size, Share & Industry Trends Analysis Report By Application (Oncology Diseases, Blood Disorders, Chronic & Autoimmune Diseases and Others), By Type, By Country and Growth Forecast, 2022 - 2028
... Market would witness market growth of 23.6% CAGR during the forecast period (2022-2028). The prevalence of autoimmune conditions like rheumatoid arthritis & ankylosing spondylitis is rising, fueling the growth of the biosimilars market. For the ... Read More
-
Global Biosimilars Market Size, Share & Industry Trends Analysis Report By Application (Oncology Diseases, Blood Disorders, Chronic & Autoimmune Diseases and Others), By Type, By Regional Outlook and Forecast, 2022 - 2028
... Market size is expected to reach $59 billion by 2028, rising at a market growth of 24.4% CAGR during the forecast period. Biosimilar medicines are biotherapeutic products that are identical to an approved reference product ... Read More
-
Global Biosimilars Market (2022 Edition) – Analysis By Product Type, Application, By Region, By Country: Market Insights and Forecast with Impact of COVID-19 (2023-2028)
... Billion in the year 2021 with the Europe region leading the regional market share. One of the main factors driving this market is the expiration of patents of major pharmaceutical drugs and thus the opportunity ... Read More
-
Disease-Modifying Antirheumatic Drug (DMARD) Market, by Drug Type (Synthetic (sDMARD), (Conventional synthetic (csDMARDs), (Methotrexate, Sulfasalazine, Leflunomide, Hydroxychloroquine and Gold Salts), Targeted synthetic DMARDs (tsDMARDs), Biological DMARDs (bDMARD), (Original DMARDs (boDMARDs), Biosimilar DMARDs (bsDMARDs), (Primary, Secondary and Tertiary) and Others), by Route of Administration (Oral, Parenteral and Others), by Indication (Rheumatoid Arthritis, Ankylosing Spondylitis, Psoriatic Arthritis, Systemic Lupus Erythematosus and Others), by Distribution Channel (Hospital Pharmacy, Retail Pharmacy and Online Pharmacy), and by Region (North America, Latin America, Europe, Asia-Pacific, Middle East & Africa) - Size, Share, Outlook, and Opportunity Analysis, 2022 - 2030
... and Tertiary) and Others), by Route of Administration (Oral, Parenteral and Others), by Indication (Rheumatoid Arthritis, Ankylosing Spondylitis, Psoriatic Arthritis, Systemic Lupus Erythematosus and Others), by Distribution Channel (Hospital Pharmacy, Retail Pharmacy and Online Pharmacy), ... Read More
-
Global Biopharmaceutical Contract Manufacturing Market 2022-2028
... to expand at a CAGR of 8.9 percent during the forecast period. The report provides in-depth analysis and insights regarding the current global market scenario, latest trends and drivers into global biopharmaceutical contract manufacturing market. ... Read More
-
Glycomic Therapeutics Market Forecast to 2028 - COVID-19 Impact and Global Analysis By Class (Isolated and Synthetic), Structures [Glycoproteins, Targeting Sialic Acid, Proteoglycans, Targeting Glycosaminoglycans, Glycosylphosphatidylinositol (GPI)-Anchored Proteins & Heparin Based Glycans, Targeting Glycosphingolipids, and Others], Indications (Thrombosis & Chemoprophylaxis, Anaemia, Anti-Adhesive & Anti-Inflammatory, Cataracts, Gaucher’s Disease, MPS-1 & IV, Cancer, Alzheimer’s Disease, Influenza Type A & B, and Others), and Mode of Action [Inhibits Neuraminidase; Inhibits Heparanase and Selectins and Blocks Interactions Between Growth Factors and Heparan Sulfate; Erythropoietin & Enzyme Replacement Therapy (ERT); Tissue Plasminogen Activator; Inhibits Glucosylceramide Synthase; Interleukin 1, 2 & 3; Beta & Gamma Interferons; and Others]
... Others], Indications (Thrombosis & Chemoprophylaxis, Anaemia, Anti-Adhesive & Anti-Inflammatory, Cataracts, Gaucher’s Disease, MPS-1 & IV, Cancer, Alzheimer’s Disease, Influenza Type A & B, and Others), and Mode of Action [Inhibits Neuraminidase; Inhibits Heparanase and Selectins ... Read More
-
Biosimilar Contract Manufacturing Market Size, Share & Trends Analysis Report By Production Technology (Mammalian, Non-Mammalian), By Application (Oncology, Blood Disorders), By Product, By Region, And Segment Forecasts, 2022 - 2030
... new report by Grand View Research, Inc. Growing demand for low-cost therapeutics and the increasing prevalence of diseases, such as cancer, autoimmune disorders, blood disorders, and other diseases are the major factors driving the industry. ... Read More
-
United States Human Insulin Market, By Product Type (Human Insulin Drugs, Human Insulin Delivery Devices); By Type (Insulin Analogs and Biosimilars, Human Insulin Biologics); By Delivery Devices (Syringes, Pens, Pen Needles); By Application (Type I Diabetes, Type II Diabetes); By Distribution Channel (Retail Pharmacies, Hospital Pharmacies, Online Pharmacies)Trend Analysis, Competitive Market Share & Forecast, 2018-2028
... Diabetes, Type II Diabetes); By Distribution Channel (Retail Pharmacies, Hospital Pharmacies, Online Pharmacies)Trend Analysis, Competitive Market Share & Forecast, 2018-2028 United States Human Insulin Market to Grow at a CAGR of 4.1% during 2022-2028 The ... Read More
-
Atopic Dermatitis Drugs Market (Drug Type: Corticosteroids, PDE4 Inhibitors, Biologics, Skin Barrier Emollients, CNI Immunosuppressants, and Others) - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2022-2031
... Report TMR’s report on the global atopic dermatitis drugs market studies the past as well as the current growth trends and opportunities to gain valuable insights of the indicators of the market during the forecast ... Read More
-
Red Biotechnology Market (Application: Biopharmaceutical Production, Gene Therapy, Pharmacogenomics, and Genetic Testing) - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2022-2031
... red biotechnology market studies the past as well as the current growth trends and opportunities to gain valuable insights of the indicators of the market during the forecast period from 2022 to 2031. The report ... Read More
-
Biopharmaceutical Contract Manufacturing Market – Global Outlook & Forecast 2022-2027
... provide capabilities and skills as needed. The CMO has provided most of the company's production in some cases. The market is mainly growing owing to the uptake of branded biologics and biosimilars, mandatory immunization programs ... Read More
-
Oncology Biosimilars Market Global Briefing 2022
... Briefing 2022 provides strategists, marketers and senior management with the critical information they need to assess the global oncology biosimilars sector. Reasons to Purchase Fully updated for 2022 Identify growth segments and opportunities. Facilitate decision ... Read More
-
Tubular Membranes Market Forecasts to 2028 – Global Analysis By Product (Organic Type, Inorganic Type), Application (Membrane Bioreactors, Reverse Osmosis, Other Applications) and By Geography
... accounted for $1.39 billion in 2022 and is expected to reach $2.77 billion by 2028 growing at a CAGR of 12.2% during the forecast period. Tubular membranes are located inside tubes made from a special ... Read More
-
Biopharmaceutical CMO Market Analysis and Forecast to 2031: By Product (Biologics, Biosimilars), Source (Mammalian, Non-mammalian), Service (Contract Manufacturing, Process Development, Packaging, Others), and Region
... is a company that provides manufacturing and other services to the pharmaceutical and biotechnology industries. CMOs are an important part of the pharmaceutical supply chain, and they play a vital role in bringing new drugs ... Read More
-
Global Bioprocess Containers Market Insights, Forecast to 2028
... in 2022 and is forecast to a readjusted size of US$ 8,244.14 million by 2028 with a CAGR of 18.51% during the forecast period 2022-2028. Global Bioprocess Containers Scope and Segment Bioprocess Containers market is ... Read More
-
Biopharmaceutical Contract Manufacturing Organization (BCMO) Market, 2022
... extensive coverage of the biotechnology segment of the global BCMO industry. Sales estimates are provided by segment and region, expressed in current dollars. Estimates are provided for the historic 2016 to 2021 period and forecasts ... Read More
-
Biohazard Bags Market By Capacity (Less than 15 gallons, 15-30 gallons, More than 30 gallons), By Material Type (Polypropylene, Polyethylene, Plastic, High-Density Polyethylene, Others), By End-use (Hospitals, Clinics, & Diagnostic Lab, Home & Ambulatory Care, Pharmaceutical & Biopharmaceutical Industries): Global Opportunity Analysis and Industry Forecast, 2021-2031
... Pharmaceutical & Biopharmaceutical Industries): Global Opportunity Analysis and Industry Forecast, 2021-2031 The global biohazard bags market is envisioned to garner $679.1 million by 2030, growing from $396.6 million in 2021 at a CAGR of 6.38% ... Read More
-
Insulin Market Forecast to 2028 - COVID-19 Impact and Global Analysis By Type [Long Acting Insulin, Rapid Acting Insulin, Short Acting Insulin & Traditional Human Insulin, Concentrated Insulin & Combination Insulin, Biosimilar Insulin, Glucagon-like peptide-1 (GLP-1), Pen & Needle, and Others] and Geography
... (GLP-1), Pen & Needle, and Others] and Geography The insulin market is projected to grow from US$ 54,611.42 million in 2021 to US$ 111,213.73 million by 2028. It is expected to grow at a CAGR ... Read More
-
Biosimilars Global Market Opportunities And Strategies To 2031
... assess the global biosimilars market as it emerges from the COVID-19 shut down. Reasons to Purchase Gain a truly global perspective with the most comprehensive report available on this market covering 12 geographies. Understand how ... Read More
-
Biopharmaceutical Excipients Market - Global Outlook and Forecast 2022-2027
... act as active ingredients, stability enhancers, emulsifying and suspending agents, binders, preservatives, antioxidants, and lubricants. These differ from prodrugs in manufacturing or are present in a finished pharmaceutical product dosage form. Excipients have targeted roles, ... Read More
-
Biosimilar Monoclonal Antibodies Market Report 2022-2032
... its underlying dynamics. It will be useful for companies that would like to expand into different industries or to expand their existing operations in a new region. Increasing Demand for Cost-Effective Biosimilars The utilization of ... Read More
-
Global Biologics and Biosimilars Market Research Report 2022 (Status and Outlook)
... biosimilars are recombinant proteins, or proteins derived from genetically engineered DNA. In this report is a biologic defined as proteins, peptides, hormones or antibodies drugs production by bio-engineered technology, but does not include a vaccine.A ... Read More
-
Market Study on Dermatology Biologics: North America Enjoys Approx. One-third Global Market Share
... and current market landscape and provides detailed analysis and updates about corresponding sections affecting the market. The study offers detailed insights on current market dynamics, which include the drivers, restraints, trends, and opportunities in the ... Read More
Research Assistance
